Karadimas Eleftherios

Karadimas Eleftherios Orthopedist

Education & Academic Qualifications

  • Master (MSc) in “Metabolic Bone Diseases” (NKUA 2010)
  • Specialty Certification in Health Management and Administration” (NKUA 2012)


  • Medical Degree of the Belgrade University of Medicine, Yugoslavia (1998)
  • Licensure of Medical Practice (1999)
  • Certification of Specialization in Orthopaedic Surgery and Traumatology (Athens 2010)


Work Experience

  • Orthopaedic Surgeon in METROPOLITAN HOSPITAL (since 2003)

  • Orthopaedic Specialist Registrar in METROPOLITAN HOSPITAL (2015)

  • Orthopaedic Surgical Fellow in the Knee Unit in the Clinic for Special Surgery, Schulthess Clinic, Zurich, Switzerland (FIFA Medical Center of Excellence) (2010-2011) 

  • Clinical and Surgical Attendant in the Lower Extremity Department, Hospital for Special Surgery, New York, USA (2011)

  • Orthopaedic Surgeon in MITERA HOSPITAL (2015) 

  • Orthopaedic Surgeon in HYGEIA HOSPITAL 


Clinical & Research Interest

  • Postgraduate – Scientific Cooperator of the Research Center for the Diseases of Musculoskeletal System, Athens (since 2008)

  • Scientific Cooperator of the Research Center for the Diseases of Musculoskeletal System at the Research protocol entitled “Epidemiological and geographical distribution of kyphosis-scoliosis in children in Greece and the correlation with hereditary and environmental factors’ under the direction of Mrs. Ismene Dontas 3376 / 17.06.2015. Study Type: Prospect. Study duration: 3 years 

  • Scientific Cooperator in Clinical Study phase III with No EUDRACT: 2005-000730-20 Research product (IMP): PTH (1-84). Pharmaceutical Company: Nycomed. Protocol: FP-001-IM. Study Title: An open label, international, multi centre, parallel group, phase III b, randomized trial, investigating lumbar spine Bone Mineral Density (BMD) changes in postmenopausal women with primary osteoporosis initially treated with 12 months of full length parathyroid hormone (PTH 1-84) followed by 12 months of treatment with risedronate followed by either 12 months treatment with PTH (1-84) or risedronate


Honors & Awards

  • Honorary Citizen of the Municipality of Leipsoi Island due to social offer to the habitants of the island (2008)

  • Conferment of Honorary Mention of Hellenic Army Marines Forces due to offer in the Greek Army (2002)


Recent Publications

  • Kalliopi Lampropoulou-Adamidou, Eleftherios V. Karadimas, Ismene Dontas, Pavlos Lelovas, Chrysoula Liakou, Nikolaos A. Papaioannou (2013) Useful animal models for the research of osteoarthritis. Eur J Orthop Surg Traumatol DOI 10.1007/s00590-013-1205-2